Australia; NSW
Long-acting medications called lipoglycopeptides, which are a type of semi-synthetic antibiotic, could be an alternative treatment to antibiotics for people with serious bacterial infections, according to Australian-led research. The long-acting drugs can be given in a single dose which can last multiple weeks. The study included around 42,000 people discharged from hospital after a serious bacterial infection, and around 800 (2%) of them were prescribed one of the long-acting drugs instead of normal antibiotics. The researchers found no statistically significant difference in outcomes between patients given the long-acting medications and those given antibiotics. The researchers say clinically, the drugs could be an effective alternative to standard antibiotic courses for serious bacterial infections.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
